Roche will publish its Full Year Results for 2021 prior to the opening of the Swiss Stock Exchange on Thursday, 3 February 2022. 07:00 CET / 06:00 GMT / 01:00 AM EST / 10:00 PM PST (evening before) Release will be e-mailed and posted on the Roche IR website >clickhere Presentation slides will be posted on the Roche IR website >click here 14:00 - 16:00 CET / 13:00 - 15:00 GMT 08:00 - 10:00 AM EST / 05:00 - 07:00 AM PST The webinar will start with presentations by senior management, followed by a Q&A session. Presenters:
Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com. A replay of the webcast will be available via >ir.roche.com *privacy notice Best regards, Karl Mahler Bruno Eschli Head of Investor Relations Head of Investor Relations |
Roche Investor Relations | |
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com |
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com |
Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com | |
Investor Relations North America | |
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Roche Holding AG published this content on 04 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 January 2022 13:08:01 UTC.